Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_assertion type Assertion NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_head.
- NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_assertion description "[Our series of IC-PBL and PT-PBL cases revealed differential expression of CD10 (0% vs. 42%, respectively), CD56 (22% vs. 42%, respectively), TP53 (67% vs. 8%, respectively), and BCL2 (88% vs. 25%, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_provenance.
- NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_assertion evidence source_evidence_literature NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_provenance.
- NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_assertion SIO_000772 24832164 NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_provenance.
- NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_assertion wasDerivedFrom befree-20150227 NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_provenance.
- NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_assertion wasGeneratedBy ECO_0000203 NP560361.RAd1tt5sjZfmbqC5muZWsRFL-sfvrftZ2VK-Qe6xavb8U130_provenance.